INCR News and Press, Intercure Ltd. From 08/15/22

InterCure press release ( NASDAQ: INCR ): Q2 net income of $6M, representing a 160% Y/Y growth Revenue of $37M. Adjusted EBITDA increased 90% year-over-year to $9 million, representing 23% of revenues and 4% sequential growth. For further details see: InterCu...

Record revenue of over $3 7 million i in the second quarter of 2022 Representing an annual run rate of $1 50 million Adjusted EBITDA ii for Q2 increased 90 % YoY to $ 9 millio...

NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the second quarter of 2022 afte...

InterCure ( NASDAQ: INCR ) Q2 revenue more than doubled Y/Y to C$36M, according to the company's preliminary Q2 results. The company anticipates continued increases in EBITDA. Also, Q3 and FY22 revenue is expected to continue to grow. For further details...

Estimated r evenue reach es CAD$3 6 million 1 ( a record NIS 95 million ) Anticipates c ontinued increase s in EBITDA Revenue growth e xpected to continue in Q 3 and throughout 20...

BOCA RATON, Fla., July 18, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the first commer...

InterCure (NASDAQ:INCR) has announced the successful opening of the first flagship Cookies store in Austria, located in the Neubau district of Vienna. The flagship location offers Cookies' unique CBD menu, available for the first time in Europe, as well as clothing and life-style products. By...

NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the successful opening of the first flagship Cookies store in Austria, located in the N...

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...